The long‐term risk of immune‐related conditions in survivors of diffuse large B‐cell lymphoma: A Danish nationwide registry study
R-CHOP-like treated patients face an increased risk of infections and AC-IDs overall compared with the background population. The risk of infections and AC-IDs did not change overall after the addition of rituximab to CHOP, however, an increased risk of respiratory infections is notable. These findings could highlight the need for expanded vigilance and prophylaxis strategies.
Authors
- Jonas Jensen (ORCID: https://orcid.org/0009-0000-1006-4751)
- Michael Roost Clausen (ORCID: https://orcid.org/0000-0003-3218-3633)
- Anne Ortved Gang (ORCID: https://orcid.org/0000-0003-0160-1257)
- Lasse Hjort Jakobsen (ORCID: https://orcid.org/0000-0001-6575-7686)
- Robert Schou Pedersen
- Thomas Stauffer Larsen (ORCID: https://orcid.org/0000-0002-8418-6708)
- Salome Kristensen (ORCID: https://orcid.org/0000-0001-5812-5234)
- Peter de Nully Brown (ORCID: https://orcid.org/0000-0002-6522-4086)
- Tarec Christoffer El‐Galaly (ORCID: https://orcid.org/0000-0002-4406-380X)
- N. O. Klausen
- Christian Bjørn Poulsen (ORCID: https://orcid.org/0000-0001-9785-1378)
- Rasmus Westermann (ORCID: https://orcid.org/0000-0002-8148-9658)
- Lene Dreyer (ORCID: https://orcid.org/0000-0002-5156-2922)
- Lars Pedersen (ORCID: https://orcid.org/0000-0002-9341-3888)
- Judit Meszaros Jørgensen (ORCID: https://orcid.org/0000-0001-9784-2703)
- Emilis Danielsen Bacevičius
Institutions
- Aarhus University (DK)
- Aalborg University Hospital (DK)
- Odense University Hospital (DK)
- Aarhus University Hospital (DK)
- Rigshospitalet (DK)
- Karolinska Institutet (SE)
- Zealand University Hospital (DK)
- Vejle Sygehus (DK)
- Regionshospitalet Herning (DK)
- Aalborg University (DK)
Publication Details
- Journal
- eJHaem
- Published
- 2024-12-28
- DOI
- https://doi.org/10.1002/jha2.1070
- Citations
- 2
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.85